Abstract
A high-throughput screen at 100 μM inhibitor concentration for the BACE-1 enzyme revealed a novel spiropiperidine iminohydantoin aspartyl protease inhibitor template. An X-ray cocrystal structure with BACE-1 revealed a novel mode of binding whereby the inhibitor interacts with the catalytic aspartates via bridging water molecules. Using the crystal structure as a guide, potent compounds with good brain penetration were designed.
Original language | English (US) |
---|---|
Pages (from-to) | 6259-6262 |
Number of pages | 4 |
Journal | Journal of medicinal chemistry |
Volume | 51 |
Issue number | 20 |
DOIs | |
State | Published - Oct 23 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery